XNAS: AVTX
Avalo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also incl...
Read More
15.80
-0.91
(-5.45%)
314.5K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Avalo Therapeutics Inc is on 20 Mar 2026 for the purpose of Avalo Therapeutics Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Avalo Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..